Latest Articles
Biomarker-Driven Decisions: Insights on Selecting Treatments in Advanced and Recurrent Endometrial Cance - OncLive
Biomarker-Driven Decisions: Insights on Selecting Treatments in Advanced and Recurrent Endometrial Cance OncLive
Published: May 19, 2025, 12:21 p.m.
Megan Wasson, DO, and Ceylan Colak, MD, share how multidisciplinary collaboration advances endometriosis diagnosis and treatment - Contemporary OB/GYN
Megan Wasson, DO, and Ceylan Colak, MD, share how multidisciplinary collaboration advances endometriosis diagnosis and treatment Contemporary OB/GYN
Published: May 19, 2025, 12:56 a.m.
[Latest] Endometriosis Treatment Market Expert-Approved Solutions In 2025 - openPR.com
[Latest] Endometriosis Treatment Market Expert-Approved Solutions In 2025 openPR.com
Published: May 15, 2025, 7:19 a.m.
Extracellular matrix stiffness in endometrial cancer: driving progression and modulating treatment sensitivity via the ROCK1/YAP1 axis - Nature
Extracellular matrix stiffness in endometrial cancer: driving progression and modulating treatment sensitivity via the ROCK1/YAP1 axis Nature
Published: May 15, 2025, 12:37 a.m.
‘I haven’t been in school since Christmas’: Teen with suspected endometriosis flies to Romania for treatment - The Irish Times
‘I haven’t been in school since Christmas’: Teen with suspected endometriosis flies to Romania for treatment The Irish Times
Published: May 13, 2025, 5:01 a.m.
Ultrasound diagnosis could lead to faster treatment of endometriosis - The Guardian
Ultrasound diagnosis could lead to faster treatment of endometriosis The Guardian
Published: May 9, 2025, 3:01 p.m.
FDA Approves Novel Treatment for KRAS-Mutated Ovarian Cancer - Medscape
FDA Approves Novel Treatment for KRAS-Mutated Ovarian Cancer Medscape
Published: May 8, 2025, 8:03 p.m.
Endometriosis treatment: same old status quo? - varsity.co.uk
Endometriosis treatment: same old status quo? varsity.co.uk
Published: May 8, 2025, 7:23 p.m.
Endometrial Cancer Phase III Shows Molecular Profiling Personalizes Treatment - Inside Precision Medicine
Endometrial Cancer Phase III Shows Molecular Profiling Personalizes Treatment Inside Precision Medicine
Published: May 7, 2025, 6:12 p.m.
Endometrial Cancer Phase III Shows Molecular Profiling, Personalizes Treatment - Inside Precision Medicine
Endometrial Cancer Phase III Shows Molecular Profiling, Personalizes Treatment Inside Precision Medicine
Published: May 7, 2025, 6:12 p.m.
Link copied to clipboard!